Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07553182 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OLE Study With Filgotinib in JIA

Name: OLE Study With Filgotinib in JIA — clinical trial record (NCT07553182)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: OLE JIA

StatusRecruiting

PhasePhase 3

SponsorAlfasigma S.p.A.

Started2026-04-20

View on ClinicalTrials.gov ↗

Amendment history

2026-08-06

Study Status, Contacts/Locations v1

Study sitesdetails revised at 1 of 4 sites

2026-04-21

Original filing

Alfasigma S.p.A.

10 trials monitored

See all monitored trials

This OLE study is designed to evaluate long-term safety, tolerability, and efficacy of filgotinib in patients with polyarticular or systemic juvenile idiopathic arthritis (pJIA-sJIA) who have completed the treatment period/prolonged treatment period of the parent studies and demonstrated clinical benefit defined as control of disease activity through improvement in signs and symptoms as per Investigator judgement.

Trial Details

NCT Number	NCT07553182
Lead Sponsor	Alfasigma S.p.A.
Conditions	Juvenile Idiopathic Arthritis (JIA)
Enrollment	80 participants
Start Date	2026-04-20
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-10